ArticleACR open rheumatology2026
Synovial Fluid Cell Profiling Identifies Distinct Inflammatory Phenotypes in Late-Onset Rheumatoid Arthritis and Polymyalgia Rheumatica.
Article in ACR open rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
objectiveLate-onset rheumatoid arthritis (LORA) and polymyalgia rheumatica (PMR) can be difficult to distinguish, particularly in anti-citrullinated protein antibody (ACPA)-negative patients. We aimed to characterize synovial fluid immune cell profiles in ACPA-positive LORA, ACPA-negative LORA, and PMR, and to explore biologically informed patient stratification using an unbiased approach.
methodsSynovial fluid was aspirated from inflamed periarticular synovial structures of the shoulder, including the subacromial and subdeltoid bursae and the tendon sheath of the long head of the biceps, in 21 patients with ACPA-positive LORA (n = 5), ACPA-negative LORA (n = 8), or PMR (n = 8). Immune cell composition was analyzed by mass cytometry. Principal component analysis and hierarchical clustering were performed to stratify patients.
resultsACPA-positive LORA demonstrated neutrophil predominance compared with PMR. In contrast, PMR demonstrated a neutrophil-poor profile characterized by higher proportions of T cells and natural killer cells. ACPA-negative LORA showed substantial heterogeneity, with individual patients displaying either neutrophil-rich or neutrophil-poor patterns. Unsupervised clustering of mass cytometry data segregated ACPA-positive LORA and PMR into distinct clusters, whereas ACPA-negative LORA cases were distributed across both clusters.
conclusionThis exploratory study suggests that late-onset inflammatory arthritis comprises at least two distinct synovial inflammatory phenotypes that may not fully correspond to current clinical diagnoses. ACPA-negative LORA appears to represent a heterogeneous condition encompassing these distinct states of inflammation. Synovial fluid immunophenotyping may complement conventional classification and support biologically informed therapeutic stratification.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.